Loading…

Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics

Infection and inflammation are associated with downregulation of hepatic and extrahepatic cytochrome P450s as well as other drug‐metabolizing enzymes and transporters. We review the genesis of inflammatory reactions and discuss the relevance of the inflammation‐related regulation of cytochrome P450...

Full description

Saved in:
Bibliographic Details
Published in:Clinical pharmacology and therapeutics 2009-04, Vol.85 (4), p.434-438
Main Author: Morgan, ET
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5312-31b7b1d506f151c3de225805fad9e9b7cd954b615bc2ba67c3aeb479a1ae38823
cites cdi_FETCH-LOGICAL-c5312-31b7b1d506f151c3de225805fad9e9b7cd954b615bc2ba67c3aeb479a1ae38823
container_end_page 438
container_issue 4
container_start_page 434
container_title Clinical pharmacology and therapeutics
container_volume 85
creator Morgan, ET
description Infection and inflammation are associated with downregulation of hepatic and extrahepatic cytochrome P450s as well as other drug‐metabolizing enzymes and transporters. We review the genesis of inflammatory reactions and discuss the relevance of the inflammation‐related regulation of cytochrome P450 enzymes to clinical drug–disease and drug–drug interactions. An understanding of the enzyme specificity and mechanisms of regulation will allow us to make better decisions about adjusting drug dosage regimens when a patient's inflammatory status changes. Clinical Pharmacology & Therapeutics (2009); 85, 4, 434–438 doi:10.1038/clpt.2008.302
doi_str_mv 10.1038/clpt.2008.302
format article
fullrecord <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3139248</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CPTCLPT2008302</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5312-31b7b1d506f151c3de225805fad9e9b7cd954b615bc2ba67c3aeb479a1ae38823</originalsourceid><addsrcrecordid>eNp9kLtu2zAUhokiReMmHbsGXDLK5UWUxCVAofRiwEE9ODNxSFExE0kUSLqFt75D37BPUqk20nbpdPDjfPwO8SP0lpIlJbx6Z7oxLRkh1ZIT9gItqOAsKwQXZ2hBCJGZZLw4R69jfJxiLqvqFTqnklHGab5A46ofwSTsW7waWmuS8_uIYWjm2EHfQ_LhgG9dtBAt9gOuD8mbXfC9xZtckJ_ff9zZxkGyDb4N-wd8ZxNo37nY_9ZsdhB6MP7JDTY5Ey_Ryxa6aN-c5gW6__hhW3_O1l8-rer368wITlnGqS41bQQpWiqo4Y1lTFREtNBIK3VpGilyXVChDdNQlIaD1XkpgYLlVcX4Bbo5ese97m1j7JACdGoMrodwUB6c-nczuJ168F8Vp1yyvJoE2VFggo8x2Pb5LSVqrl7N1au5ejVVP_FXfx_8Q5-6noDrEwDRQNcGGIyLz9xE5axks0geuW-us4f_X1X1ZluvN9s5z5_4BcN8oZs</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics</title><source>Wiley</source><creator>Morgan, ET</creator><creatorcontrib>Morgan, ET</creatorcontrib><description>Infection and inflammation are associated with downregulation of hepatic and extrahepatic cytochrome P450s as well as other drug‐metabolizing enzymes and transporters. We review the genesis of inflammatory reactions and discuss the relevance of the inflammation‐related regulation of cytochrome P450 enzymes to clinical drug–disease and drug–drug interactions. An understanding of the enzyme specificity and mechanisms of regulation will allow us to make better decisions about adjusting drug dosage regimens when a patient's inflammatory status changes. Clinical Pharmacology &amp; Therapeutics (2009); 85, 4, 434–438 doi:10.1038/clpt.2008.302</description><identifier>ISSN: 0009-9236</identifier><identifier>EISSN: 1532-6535</identifier><identifier>DOI: 10.1038/clpt.2008.302</identifier><identifier>PMID: 19212314</identifier><identifier>CODEN: CLPTAT</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing Group</publisher><subject>Animals ; Biological and medical sciences ; Communicable Diseases - enzymology ; Communicable Diseases - pathology ; Cytochrome P-450 Enzyme System - metabolism ; Down-Regulation - physiology ; Drug Interactions - physiology ; Humans ; Inflammation - metabolism ; Inflammation Mediators - physiology ; Medical sciences ; Pharmaceutical Preparations - metabolism ; Pharmacology. Drug treatments</subject><ispartof>Clinical pharmacology and therapeutics, 2009-04, Vol.85 (4), p.434-438</ispartof><rights>2009 American Society for Clinical Pharmacology and Therapeutics</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5312-31b7b1d506f151c3de225805fad9e9b7cd954b615bc2ba67c3aeb479a1ae38823</citedby><cites>FETCH-LOGICAL-c5312-31b7b1d506f151c3de225805fad9e9b7cd954b615bc2ba67c3aeb479a1ae38823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21242722$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19212314$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Morgan, ET</creatorcontrib><title>Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics</title><title>Clinical pharmacology and therapeutics</title><addtitle>Clin Pharmacol Ther</addtitle><description>Infection and inflammation are associated with downregulation of hepatic and extrahepatic cytochrome P450s as well as other drug‐metabolizing enzymes and transporters. We review the genesis of inflammatory reactions and discuss the relevance of the inflammation‐related regulation of cytochrome P450 enzymes to clinical drug–disease and drug–drug interactions. An understanding of the enzyme specificity and mechanisms of regulation will allow us to make better decisions about adjusting drug dosage regimens when a patient's inflammatory status changes. Clinical Pharmacology &amp; Therapeutics (2009); 85, 4, 434–438 doi:10.1038/clpt.2008.302</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Communicable Diseases - enzymology</subject><subject>Communicable Diseases - pathology</subject><subject>Cytochrome P-450 Enzyme System - metabolism</subject><subject>Down-Regulation - physiology</subject><subject>Drug Interactions - physiology</subject><subject>Humans</subject><subject>Inflammation - metabolism</subject><subject>Inflammation Mediators - physiology</subject><subject>Medical sciences</subject><subject>Pharmaceutical Preparations - metabolism</subject><subject>Pharmacology. Drug treatments</subject><issn>0009-9236</issn><issn>1532-6535</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp9kLtu2zAUhokiReMmHbsGXDLK5UWUxCVAofRiwEE9ODNxSFExE0kUSLqFt75D37BPUqk20nbpdPDjfPwO8SP0lpIlJbx6Z7oxLRkh1ZIT9gItqOAsKwQXZ2hBCJGZZLw4R69jfJxiLqvqFTqnklHGab5A46ofwSTsW7waWmuS8_uIYWjm2EHfQ_LhgG9dtBAt9gOuD8mbXfC9xZtckJ_ff9zZxkGyDb4N-wd8ZxNo37nY_9ZsdhB6MP7JDTY5Ey_Ryxa6aN-c5gW6__hhW3_O1l8-rer368wITlnGqS41bQQpWiqo4Y1lTFREtNBIK3VpGilyXVChDdNQlIaD1XkpgYLlVcX4Bbo5ese97m1j7JACdGoMrodwUB6c-nczuJ168F8Vp1yyvJoE2VFggo8x2Pb5LSVqrl7N1au5ejVVP_FXfx_8Q5-6noDrEwDRQNcGGIyLz9xE5axks0geuW-us4f_X1X1ZluvN9s5z5_4BcN8oZs</recordid><startdate>200904</startdate><enddate>200904</enddate><creator>Morgan, ET</creator><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>200904</creationdate><title>Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics</title><author>Morgan, ET</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5312-31b7b1d506f151c3de225805fad9e9b7cd954b615bc2ba67c3aeb479a1ae38823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Communicable Diseases - enzymology</topic><topic>Communicable Diseases - pathology</topic><topic>Cytochrome P-450 Enzyme System - metabolism</topic><topic>Down-Regulation - physiology</topic><topic>Drug Interactions - physiology</topic><topic>Humans</topic><topic>Inflammation - metabolism</topic><topic>Inflammation Mediators - physiology</topic><topic>Medical sciences</topic><topic>Pharmaceutical Preparations - metabolism</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Morgan, ET</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical pharmacology and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Morgan, ET</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics</atitle><jtitle>Clinical pharmacology and therapeutics</jtitle><addtitle>Clin Pharmacol Ther</addtitle><date>2009-04</date><risdate>2009</risdate><volume>85</volume><issue>4</issue><spage>434</spage><epage>438</epage><pages>434-438</pages><issn>0009-9236</issn><eissn>1532-6535</eissn><coden>CLPTAT</coden><abstract>Infection and inflammation are associated with downregulation of hepatic and extrahepatic cytochrome P450s as well as other drug‐metabolizing enzymes and transporters. We review the genesis of inflammatory reactions and discuss the relevance of the inflammation‐related regulation of cytochrome P450 enzymes to clinical drug–disease and drug–drug interactions. An understanding of the enzyme specificity and mechanisms of regulation will allow us to make better decisions about adjusting drug dosage regimens when a patient's inflammatory status changes. Clinical Pharmacology &amp; Therapeutics (2009); 85, 4, 434–438 doi:10.1038/clpt.2008.302</abstract><cop>Basingstoke</cop><pub>Nature Publishing Group</pub><pmid>19212314</pmid><doi>10.1038/clpt.2008.302</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-9236
ispartof Clinical pharmacology and therapeutics, 2009-04, Vol.85 (4), p.434-438
issn 0009-9236
1532-6535
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3139248
source Wiley
subjects Animals
Biological and medical sciences
Communicable Diseases - enzymology
Communicable Diseases - pathology
Cytochrome P-450 Enzyme System - metabolism
Down-Regulation - physiology
Drug Interactions - physiology
Humans
Inflammation - metabolism
Inflammation Mediators - physiology
Medical sciences
Pharmaceutical Preparations - metabolism
Pharmacology. Drug treatments
title Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and Pharmacokinetics
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T23%3A31%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Infectious%20and%20Inflammatory%20Disease%20on%20Cytochrome%20P450%E2%80%93Mediated%20Drug%20Metabolism%20and%20Pharmacokinetics&rft.jtitle=Clinical%20pharmacology%20and%20therapeutics&rft.au=Morgan,%20ET&rft.date=2009-04&rft.volume=85&rft.issue=4&rft.spage=434&rft.epage=438&rft.pages=434-438&rft.issn=0009-9236&rft.eissn=1532-6535&rft.coden=CLPTAT&rft_id=info:doi/10.1038/clpt.2008.302&rft_dat=%3Cwiley_pubme%3ECPTCLPT2008302%3C/wiley_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5312-31b7b1d506f151c3de225805fad9e9b7cd954b615bc2ba67c3aeb479a1ae38823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/19212314&rfr_iscdi=true